205 related articles for article (PubMed ID: 32617881)
1. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
[TBL] [Abstract][Full Text] [Related]
2. Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation.
El Hachem H; Sonigo C; Benard J; Presse M; Sifer C; Sermondade N; Grynberg M
PLoS One; 2018; 13(12):e0208576. PubMed ID: 30521621
[TBL] [Abstract][Full Text] [Related]
3. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
4. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
5. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience.
Reddy J; Turan V; Bedoschi G; Moy F; Oktay K
J Assist Reprod Genet; 2014 Jul; 31(7):927-32. PubMed ID: 24854484
[TBL] [Abstract][Full Text] [Related]
6. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
7. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
[TBL] [Abstract][Full Text] [Related]
8. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
9. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
[TBL] [Abstract][Full Text] [Related]
10. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
Creux H; Monnier P; Son WY; Tulandi T; Buckett W
Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
[TBL] [Abstract][Full Text] [Related]
11. Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome.
Zheng X; Wang L; Zhen X; Lian Y; Liu P; Qiao J
Reprod Biol Endocrinol; 2012 May; 10():40. PubMed ID: 22621829
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
13. In-vitro maturation of germinal vesicle and metaphase I eggs prior to cryopreservation optimizes reproductive potential in patients undergoing fertility preservation.
Lee JA; Sekhon L; Grunfeld L; Copperman AB
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):168-73. PubMed ID: 24752002
[TBL] [Abstract][Full Text] [Related]
14. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
[TBL] [Abstract][Full Text] [Related]
15. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency.
Grynberg M; Jacquesson L; Sifer C
Fertil Steril; 2020 Oct; 114(4):848-853. PubMed ID: 32709383
[TBL] [Abstract][Full Text] [Related]
16. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
17. Added Benefit of Immature Oocyte Maturation for Fertility Preservation in Women with Malignancy.
Cohen Y; Tannus S; Volodarsky-Perel A; Son WY; Tulandi T; Buckett W
Reprod Sci; 2020 Dec; 27(12):2257-2264. PubMed ID: 32617879
[TBL] [Abstract][Full Text] [Related]
18. In vitro maturation of immature oocytes from ovarian tissue prior to shipment to a cryobank.
Dietrich JE; Jauckus J; Hoffmann S; Liebenthron J; Capp E; Strowitzki T; Germeyer A
Arch Gynecol Obstet; 2020 Oct; 302(4):1019-1024. PubMed ID: 32556511
[TBL] [Abstract][Full Text] [Related]
19. Priming with a gonadotropin-releasing hormone agonist before immature oocyte retrieval may improve maturity of oocytes and outcome in in vitro maturation (IVM) cycle: a case report.
Smirnova A; Anshina M; Paz ES; Ellenbogen A
J Med Case Rep; 2021 Mar; 15(1):134. PubMed ID: 33771223
[TBL] [Abstract][Full Text] [Related]
20. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
